Andrew Dalovisio is an Oncology physician affiliated with Ochsner Health System. OpenAlex indexes 24 publications with 446 citations (h-index 9).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4950 Essen Ln Ste 500
Baton Rouge, LA 708093738
Telephone
225-767-0847Provider last certified this registry record 8 May 2025.
Industry payments
33 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Janssen Biotech, Inc.Program year202519 payments$17,844openpaymentsdata.cms.gov ↗
- AstraZeneca Pharmaceuticals LPProgram year202510 payments
- Genmab U.S., Inc.Program year20259 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
31.2%Thalidomide Analog23.4%Lenalidomide55%Revlimid27%Pomalyst18%Part D≥60 patientsKinase inhibitor3%Imbruvica37%Brukinsa28%Jakafi20%Calquence15%Part D<11 patients+ 6 more classes in this area
Nervous system
25.7%Opioid Agonist12.5%Oxycodone Hcl33%Oxycodone-Acetaminophen26%Morphine Sulfate Er15%Tramadol Hcl10%Oxycontin7%Hydromorphone Hcl5%Methadone Hcl4%Part D<11 patientsGabapentinoids4.6%Gabapentin84%Pregabalin16%Part D<11 patients+ 7 more classes in this area
Dermatology
13.3%Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor13.3%Acyclovir100%Part D≥81 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Carl Lavie, MD
Ochsner Health System
Natalie Bzowej, MD
Ochsner Health System
Mark Effron, MD
Ochsner Health System
Jane Martin, MD
Ochsner Health System
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”